Larson S - Search Results

1

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.

Solit DB, Ivy SP, Kopil C, Sikorski R, Morris MJ, Slovin SF, Kelly WK, DeLaCruz A, Curley T, Heller G, Larson S, Schwartz L, Egorin MJ, Rosen N, Scher HI. Solit DB, et al. Among authors: larson s. Clin Cancer Res. 2007 Mar 15;13(6):1775-82. doi: 10.1158/1078-0432.CCR-06-1863. Clin Cancer Res. 2007. PMID: 17363532 Free PMC article. Clinical Trial.

2

Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors.

Scher HI, Curley T, Yeh S, Tong W, O'Moore PV, Larson S. Scher HI, et al. Among authors: larson s. Adv Exp Med Biol. 1992;324:115-29. doi: 10.1007/978-1-4615-3398-6_12. Adv Exp Med Biol. 1992. PMID: 1283494 Review. No abstract available.

3

Therapeutic alternatives for hormone-refractory prostatic cancer.

Scher HI, Curley T, Yeh S, Iversen JM, O'Dell M, Larson SM. Scher HI, et al. Among authors: larson sm. Semin Urol. 1992 Feb;10(1):55-64. Semin Urol. 1992. PMID: 1373515 Review.

4

Advances in imaging.

Larson SM, Schwartz LH. Larson SM, et al. Semin Oncol. 1994 Oct;21(5):598-606. Semin Oncol. 1994. PMID: 7939750 Review. No abstract available.

5

Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer.

Welt S, Divgi CR, Kemeny N, Finn RD, Scott AM, Graham M, Germain JS, Richards EC, Larson SM, Oettgen HF, et al. Welt S, et al. Among authors: larson sm. J Clin Oncol. 1994 Aug;12(8):1561-71. doi: 10.1200/JCO.1994.12.8.1561. J Clin Oncol. 1994. PMID: 8040668 Clinical Trial.

6

Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.

Cheung NK, Cheung IY, Canete A, Yeh SJ, Kushner B, Bonilla MA, Heller G, Larson SM. Cheung NK, et al. Among authors: larson sm. Cancer Res. 1994 Apr 15;54(8):2228-33. Cancer Res. 1994. PMID: 8174131

7

Treatment of spinal epidural neuroblastoma xenografts in rats using anti-GD2 monoclonal antibody 3F8.

Bergman I, Arbit E, Rosenblum M, Larson SM, Heller G, Cheung NK. Bergman I, et al. Among authors: larson sm. J Neurooncol. 1993 Mar;15(3):235-42. doi: 10.1007/BF01050069. J Neurooncol. 1993. PMID: 8360709

8

Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma.

Czuczman MS, Straus DJ, Divgi CR, Graham M, Garin-Chesa P, Finn R, Myers J, Old LJ, Larson SM, Scheinberg DA. Czuczman MS, et al. Among authors: larson sm. J Clin Oncol. 1993 Oct;11(10):2021-9. doi: 10.1200/JCO.1993.11.10.2021. J Clin Oncol. 1993. PMID: 8410126 Clinical Trial.

9

Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer.

Welt S, Scott AM, Divgi CR, Kemeny NE, Finn RD, Daghighian F, Germain JS, Richards EC, Larson SM, Old LJ. Welt S, et al. Among authors: larson sm. J Clin Oncol. 1996 Jun;14(6):1787-97. doi: 10.1200/JCO.1996.14.6.1787. J Clin Oncol. 1996. PMID: 8656247 Clinical Trial.

10

Detection of bony metastases of androgen-independent prostate cancer by PET-FDG.

Yeh SD, Imbriaco M, Larson SM, Garza D, Zhang JJ, Kalaigian H, Finn RD, Reddy D, Horowitz SM, Goldsmith SJ, Scher HI. Yeh SD, et al. Among authors: larson sm. Nucl Med Biol. 1996 Aug;23(6):693-7. doi: 10.1016/0969-8051(96)00044-3. Nucl Med Biol. 1996. PMID: 8940712 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,857 results

Search Page

Filters